Deep Track Capital, LP Regulus Therapeutics Inc. Transaction History
Deep Track Capital, LP
- $3.03 Billion
- Q1 2024
A detailed history of Deep Track Capital, LP transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 3,266,566 shares of RGLS stock, worth $6.99 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
3,266,566Holding current value
$6.99 Million% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding RGLS
# of Institutions
47Shares Held
36.4MCall Options Held
239KPut Options Held
12.6K-
Federated Hermes, Inc. Pittsburgh, PA12.9MShares$27.5 Million0.09% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$10.7 Million1.93% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.68MShares$7.87 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.88MShares$4.01 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT1.56MShares$3.34 Million0.37% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $31.3M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...